Expert Debate: Is continuous therapy in multiple myeloma inevitable or impractical?

Professor Gordon Cook chairs an expert debate, between Consultant Haematologists Professor Graham Jackson and Dr Karthik Ramasamy, as they discuss their opinions regarding the role of continuous therapy in multiple myeloma.

Professor Graham Jackson, Newcastle Hospitals NHS Foundation Trust and the University of Newcastle, outlines the prospects and potential benefits of continuous therapy for the treatment of multiple myeloma whilst Dr Karthik Ramasamy, Royal Berkshire and Oxford University Hospitals NHS Foundation Trusts, highlights the practical challenges involved in the implementation of continuous therapy into routine clinical practice.

The views expressed in this video are those of the speakers.

To view expert biographies please visit the Myeloma Hub Faculty page.

UK/NP/1806/0035r - August 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.